InnerScope Hearing Technologies (OTC: INND) Announces Partnership with Atlazo Inc.
InnerScope Hearing Technologies (OTC: INND) announced a partnership with Atlazo Inc. to develop innovative smart hearing devices, leveraging Atlazo's AI hardware platform. This collaboration aims to enhance user experience through features like voice commands and continuous health monitoring. The products will feature an ultra-low power System-on-Chip, reducing costs and time-to-market for manufacturers. With over 12 patents protecting their technology, InnerScope plans to dominate the direct-to-consumer hearing device market, especially following recent FDA regulations enhancing accessibility.
- Partnership with Atlazo expected to drive innovation in hearing aids.
- New devices will include advanced features like health monitoring and voice commands.
- Over 12 patents protect the technology, enhancing competitive advantage.
- Alignment with recent FDA OTC regulations may boost market access.
- None.
Partnership with semiconductor innovator creates new types of smart wireless hearing devices, offering consumers unprecedented connectivity for health and IoT applications
ROSEVILLE, Calif., Nov. 11, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- InnerScope Hearing Technologies Inc. (OTC: INND) ("InnerScope"), the leader in direct-to-consumer (DTC) and over-the-counter (OTC) hearing solutions, announced today its partnership with Atlazo Inc. ("Atlazo") to develop next-generation hearing aids and hearable products, utilizing Atlazo's patented Artificial Intelligence (AI) hardware platform. Hearing products powered by Atlazo's proprietary ultra-low power System-on-Chip (SoC) will offer consumers unprecedented new features, including voice commands, continuous health monitoring, and seamless connectivity with other smart devices.
Mr. Adnan Shennib, Chief Technology Officer of InnerScope, stated: "Consumers will not only benefit from improved hearing in noisy environments but also from natural ways to interact with other wireless devices, including mobile phones, providing an enhanced, more convenient, user experience."
Atlazo's integrated digital hardware platform reduces cost and time-to-market for manufacturers of wearable devices. The SoC platforms include software algorithms designed specifically for wearable healthcare applications. The Atlazo and InnerScope collaboration targeting hearing applications are protected by over 12 issued and pending patents.
"We are pleased to join forces with InnerScope and its iHEAR team to develop new types of smart hearing products, leveraging iHEAR's extensive domain experience in hearing health," stated Karim Arabi, Founder and CEO of Atlazo. "Offering new types of intelligent hearing products with improved performance and affordability will be welcomed by tech-savvy consumers looking for alternatives to conventional hearing aids."
Matthew Moore, President and CEO of InnerScope Hearing Technologies, commented, "With the recent FDA OTC regulations being released last month, including a landmark proposal intended to improve access to and reduce the cost of hearing aid technology for millions of Americans, and the anticipation of this OTC Law to be enacted soon, InnerScope is continuing to execute its plan to be the leader in the direct-to-consumer hearing device market. The Atlazo partnership and our iHear research and development team give InnerScope the ability to develop new innovative types of proprietary artificial intelligence-powered hearing products that transcend today's hearing devices so all consumers, whether they have hearing loss or not, can benefit from using them."
About InnerScope Hearing Technologies, Inc. (OTC PINK: INND):
InnerScope Hearing Technologies Inc. is a leading manufacturer and distributor of FDA-registered hearing aids and Personal Sound Amplifier Products (PSAPs) dedicated to addressing the global demand for affordable hearing solutions. InnerScope's hearing products and business models breakthrough persistent barriers that prevent access to effective hearing solutions. With the recent Acquisition of iHear Medical Inc., a cloud-based hearing solution provider with access to over 40 patents, and the completion of HearingAssist Acquisition, an established leader in the direct-to-consumer hearing aid market with over 400,000 customers, InnerScope is well-positioned to expand its distribution partnership network and its leadership in the direct-to-consumer hearing solutions market with advanced hearing products offered at a fraction of the cost of conventional hearing aids sold in hearing aid centers. For more information, please visit www.innd.com.
For the most up-to-date information about InnerScope Hearing Technologies (OTC: INND), please visit and follow our official Twitter account @inndstock page:
For information related to InnerScope Hearing Technologies latest hearing aids and related hearing products, please visit:
http://myheariq.com
About Atlazo:
Atlazo is the leader in intelligent semiconductor solutions for healthcare and wearable, targeting the rapidly growing hearing and wearable health device markets. Founded in 2016 and headquartered in San Diego, CA, the company is dedicated to addressing the global demand for more reliable health tracking and audio by bringing together cutting-edge innovations in energy-efficient AI and flexible bio-sensing interface in a single System-on-Chip (SoC) solution. Atlzao's innovative SoC products offer manufacturers a platform for rapid development of wearable healthcare products, dramatically reducing costs and time-to-market. For more information on Atlazo Inc., please visit: http://www.atlazo.com
Safe Harbor
This news release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended intended to be covered by the "safe harbor" created by those sections. Any statements that are not historical facts contained in this press release are also "forward-looking statements," as that term is defined under the Private Securities Litigation Reform Act of 1995 (PSLRA). Such statements may be identified by words such as "expects," "plans," "projects," "will," "may," "anticipates," "believes," "should," "intends," "estimates," and other words of similar meaning. Such forward-looking statements are based on current expectations, involve known and unknown risks, a reliance on third parties for information, transactions or orders that may be canceled, and other factors that may cause our actual results, performance or achievements, or developments in our industry, to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from anticipated results include risks and uncertainties related to the fluctuation of global economic conditions, the performance of management and our employees, our ability to obtain financing or maintain contractual relationships with vendors and customers, competition, general economic conditions and other factors that are detailed in our periodic reports filed with the Securities and Exchange Commission ("S.E.C."). We intend that all forward-looking statements be subject to the safe-harbor provisions of the PSLRA, Securities Act, and Securities Exchange Act.
Contact:
InnerScope Hearing Technologies, Inc.
Investor Relations
ir@innd.com
833-788-0506
www.innd.com
Investor Relations Agency Contact:
Skyline Corporate Communications Group, LLC
Lisa Gray, Senior Account Manager
One Rockefeller Plaza, 11th Floor
New York, NY 10020
Office: (646) 893-5835
Email: lisa@skylineccg.com
InnerScope Hyperlinks:
Acquisition of iHear Medical Inc.
HearingAssist Acquisition
Corporate Communications:
InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com
FAQ
What is InnerScope's latest partnership about?
How will the partnership with Atlazo benefit InnerScope?
What features will the new hearing devices have?
How many patents protect InnerScope's technology?
What recent regulations impact InnerScope's market strategy?
